News
Appraising Ultra-Orphan Drugs: Is Cost-per-QALY Appropriate?
22 March 2018
A new OHE report discusses NICE’s introduction of a cost-effectiveness threshold to appraise ultra-orphan drugs.
Minimal Access Surgery – Why Don’t We Do More?
20 March 2018
OHE Consulting publishes a report on the barriers to the uptake of minimal access surgery in the NHS and private sector.
Why are Mortality Rates Rising for Middle-Aged White Non-Hispanic Americans? Could it Happen in Europe? 24th Annual Lecture Publication
19 March 2018
Download OHE’s 24th Annual Lecture publication: Why are Mortality Rates Rising for Middle-Aged White Non-Hispanic Americans? Could it Happen in Europe?
Our Contributions to the Economics of Personalised Medicine
7 March 2018
OHE has authored numerous papers on personalised medicine with contributions to value frameworks, innovations in pricing and cost effectiveness analyses.
Cancer Survivorship Burden
6 March 2018
A new paper entitled “Survivorship Burden for Individuals, Households and Society: Estimates and Methodology” has been published in the Journal of Cancer Policy.
OHE Lunchtime Seminar: Valuing Children’s Health for Economic Evaluation
15 February 2018
OHE Lunchtime Seminar with Oliver Rivero-Arias on Valuing Children’s Health for Economic Evaluation. 29 March 2018 12:00-2:00pm
Experience-Based Values: A Framework for Classifying Different Types of Experience in Health Valuation Research
7 February 2018
OHE’s Patricia Cubi-Molla and Koonal Shah, with Kristina Burström, propose a new framework for classifying experience in health valuation research.
Comparing Preference-based Outcome Measures for Overactive Bladder: EQ-5D-5L vs OAB-5D
31 January 2018
A recent paper examines EQ-5D-5L outcomes in patients with overactive bladder and compares them to results on the OAB-5D, a condition-specific measure.
Seminar Briefing: NHS Agency Staffing and the Impact of Recent Interventions
24 January 2018
A new OHE Seminar Briefing by Chris Mullin, Chief Economist at the Department of Health, examines growth in expenditure on NHS agency staffing.